Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesIdentification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells
Oncogene, 05/13/08
Makkonen H et al. - ELK4 is a direct AR target in prostate cancer cells. Androgens may thus contribute to the growth of prostate cancer via influencing ELK4 levels.
| Previous Article | Next Article |
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?
Cancer, 06/04/09
Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95
Journal of Clinical Oncology, 06/22/09
Early salvage radiotherapy for patients with PSA relapse after radical prostatectomy
Journal of Cancer Research & Clinical Oncology, 06/03/09
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?
Cancer, 06/04/09
Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95
Journal of Clinical Oncology, 06/22/09
Early salvage radiotherapy for patients with PSA relapse after radical prostatectomy
Journal of Cancer Research & Clinical Oncology, 06/03/09
Article Search
Sponsor